BLOOMFIELD, Conn., Sept. 12, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), launched an "E-Treatment" option through MDLIVE by Evernorth. Beginning this month, customers have quick, flexible access to urgent care from board-certified doctors, without any direct interaction via phone or video.
For many common, lower-risk conditions, such as allergies, eye or ear infections, urinary tract infections, and some respiratory illnesses like the flu, customers can submit a virtual clinical interview through the MDLIVE portal, and typically within one hour, they will receive their diagnoses and personalized treatment plans.
"Our customers lead busy lives, and getting care shouldn't be put on the backburner," said Heather Dlugolenski, U.S. employer strategy officer, Cigna Healthcare. "By offering customers multiple ways to conveniently connect with board-certified clinicians, they can be more effective with their time and continue putting their health and vitality first."
Through www.myCigna.com, customers click "Talk to a Doctor" to get started with MDLIVE's virtual urgent E-Treatment option. The virtual clinical interview typically takes 8-10 minutes to complete. Once submitted, MDLIVE board-certified doctors review the information and share back a diagnosis and treatment plan. Customers are notified through a text or email when their visit summary is ready, and any needed prescriptions are sent to the customer's preferred pharmacy. If a higher level of care is needed, a customer's care can be escalated to a video visit with the same doctor or to in-person care.
"Patients and doctors alike recognize that some conditions shouldn't require patients to wait to speak with a doctor to begin having their illness assessed," said Dr. Eric Weil, chief medical officer, MDLIVE. "We want to offer multiple options in the way that patients access care, and our clients are demanding that. While not a substitute for seeing a provider in person for more serious conditions, E-Treatment enables choice and flexibility for patients. It also frees up clinicians to practice at the top of their license by spending time with patients when direct interaction is really needed."
Internal data show that 99% of patients are happy with their experience[1], and 34% were using MDLIVE virtual care for the first time.[2] E-Treatment, which is powered by MDLIVE's acquisition of the platform and technology from Bright.md, is now available to customers* who have Cigna Healthcare insurance through the Affordable Care Act individual marketplace or their employer, many of whom have access to the service with a $0 co-pay. Many Cigna Healthcare customers also have access to virtual urgent care, primary care, behavioral (therapy and psychology) and dermatology.
*E-Treatment is available in U.S. states, except: Kansas, Mississippi, New Mexico, West Virginia and the District of Columbia.
About Cigna Healthcare
Cigna Healthcare is a health benefits provider that advocates for better health through every stage of life. We guide our customers through the health care system, empowering them with the information and insight they need to make the best choices for improving their health and vitality. Products and services are provided exclusively by or through operating subsidiaries of The Cigna Group (NYSE:CI), including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth Health companies or their affiliates and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits and others. Learn more at CignaHealthcare.com.
1 Cigna Healthcare internal reporting among customers with pilot access to E-Treatment who provided in-app feedback, July 2024
2 Cigna Healthcare internal reporting of accounts with pilot access to E-Treatment, June 2024
Media Contact:
Jocelyn Parker
313-510-4173
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$312.32 |
Daily Change: | -0.57 -0.18 |
Daily Volume: | 1,315,126 |
Market Cap: | US$87.310B |
October 31, 2024 September 12, 2024 August 01, 2024 May 23, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORETerns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB